Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -70,845 | -64,116 | -48,419 | -151,584 | -117,741 |
| Depreciation Amortization | 8,171 | 5,427 | 2,685 | 10,489 | 7,771 |
| Income taxes - deferred | N/A | N/A | N/A | -4,939 | -4,939 |
| Accounts receivable | -9,090 | -447 | 9,557 | -20,108 | -8,614 |
| Other Working Capital | -55,204 | -11,226 | -22,318 | -47,990 | -48,686 |
| Other Operating Activity | 96,993 | 63,358 | 28,800 | 145,041 | 99,660 |
| Operating Cash Flow | $-29,975 | $-7,004 | $-29,695 | $-69,091 | $-72,549 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 23,097 | -11,531 | 9,348 | 105,504 | 127,730 |
| PPE Investments | -3,265 | -2,909 | -1,811 | -7,440 | -5,709 |
| Investing Cash Flow | $19,832 | $-14,440 | $7,537 | $98,064 | $122,021 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 387,360 | N/A |
| Debt Repayment | -54 | -78 | -42 | -408,318 | -82 |
| Common Stock Issued | 25,275 | 4,317 | 3,454 | 103,208 | 70,967 |
| Common Stock Repurchased | -21,197 | -18,405 | -16,721 | -17,920 | -16,355 |
| Other Financing Activity | 0 | 0 | 0 | -2,653 | -1,063 |
| Financing Cash Flow | $4,024 | $-14,166 | $-13,309 | $61,677 | $53,467 |
| Exchange Rate Effect | -7,138 | -2,110 | -1,816 | 6,312 | 10,218 |
| Beginning Cash Position | 250,077 | 250,077 | 250,077 | 153,115 | 153,115 |
| End Cash Position | 236,820 | 212,357 | 212,794 | 250,077 | 266,272 |
| Net Cash Flow | $-13,257 | $-37,720 | $-37,283 | $96,962 | $113,157 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,975 | -7,004 | -29,695 | -69,091 | -72,549 |
| Capital Expenditure | -3,265 | -2,909 | -1,811 | -7,440 | -5,709 |
| Free Cash Flow | -33,240 | -9,913 | -31,506 | -76,531 | -78,258 |